Lv5
1510 积分 2025-09-19 加入
A Road Map to GMP Readiness for Protein Therapeutics – Drug Product Process Development for Clinical Supply
1个月前
已完结
Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality
1个月前
已完结
Lux is not just lux: Method for determining the photostability of drug products
1个月前
已关闭
Effect of ambient light on IgG1 monoclonal antibodies during drug product processing and development
1个月前
已完结
Mechanistic and predictive formulation development for viscosity mitigation of high-concentration biotherapeutics
3个月前
已完结
Caffeine as a Viscosity-Reducing Agent for High-Concentration mAb Formulations: Insights from Molecular Dynamics Simulations
3个月前
已完结
Preclinical Pharmacokinetic Study on Caffeine as an Excipient for Monoclonal Antibody Formulations
3个月前
已关闭
Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions
3个月前
已完结
HP-β-CD for the formulation of IgG and Ig-based biotherapeutics
3个月前
已完结
Identification and Root Cause Analysis of the Visible Particles Commonly Encountered in the Biopharmaceutical Industry
3个月前
已完结
皖公网安备34019202002308
